Atomoxetine-induced hypomania-like symptoms in a preadolescent patient.
Ankara Pediatric & Pediatric Hematology Oncology Training and Research Hospital , Child and Adolescent Psychiatry Department, Ankara, Turkey .
Esra
E
Guney
Ozden Sukran
OS
Uneri
D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects*; D001008:Anxiety Disorders / Q000188:drug therapy*; D000069445:Atomoxetine Hydrochloride; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D001714:Bipolar Disorder / Q000139:chemically induced*; D002648:Child; D006801:Humans; D008297:Male; D011437:Propylamines / Q000009:adverse effects*
D018759:Adrenergic Uptake Inhibitors; D011437:Propylamines; D000069445:Atomoxetine Hydrochloride